About
EndoQuest Robotics is a Houston-based medical technology company that specializes in developing advanced robotic surgical systems for minimally invasive surgeries. Their flagship product, the ENDOQUEST Endoluminal Surgical (ELS) System, is recognized as the world's first flexible endoluminal robotic surgical system. This innovative platform allows surgeons to perform upper and lower gastrointestinal surgeries through natural orifices or single-incision approaches, significantly reducing the need for external incisions. The ELS System features flexible instrumentation with up to seven degrees of freedom, enabling complex procedures that traditional methods find challenging. EndoQuest's technology aims to enhance patient outcomes by minimizing trauma, accelerating recovery times, and reducing visible scarring and healthcare costs. The company has received $42 million in funding and has FDA Investigational Device Exemption approval for its PARADIGM clinical trials, which are being conducted at leading U.S. healthcare institutions. With a dedicated team of around 60 employees, EndoQuest Robotics is committed to advancing surgical robotics and improving patient care.
Technologies
Keywords
Company Information
-
Employees 72
-
Founded 2017
-
Annual Revenue $7800000
-
Total Funding $159488638
Location
9310 Kirby Dr, Houston, Texas, United States, 77054-2515